Revolutionizing Alzheimer's care, Zunveyl minimizes GI and sleep side effects. Discover its market potential and why it's ...

Hodgkin's lymphoma and acute lymphoblastic leukemia—two types of cancer that affect blood cells—do not respond adequately to treatment with CAR-T cells. The therapy involves harvesting the patient's ...

A new generation of checkpoint inhibitors is emerging, with some showing more promise than others. From recent TIGIT failures ...

Panelists discuss how currently available ALK inhibitors compare in terms of efficacy, durability of response, and central ...

Global Antiscalants/ Scale inhibitors market is valued approximately USD 2.71 Billion in 2018 and is anticipated to grow with a growth rate of more than 4.69% over the forecast period 2019-2026. Scale ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system ...

3.2. Soil Remediation Approaches and Application Prospects of Mixed Microbial Agents ...